IDH1 and central nervous system cancer: When IDH1 or IDH2 is mutated in gliomas (most frequently at codon R132 or R172, respectively), the mutated protein gains a neomorphic enzymatic activity, and produces D-2-hydroxyglutarate (2-HG) from α-ketoglutarate (α-KG).